Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Anti-TNF therapy can cause a unique type of hair loss that may get better with topical treatments without stopping the therapy.

Shrinking of oil glands in the skin is a key sign of hair loss linked to TNF inhibitor drugs and may improve if the treatment is stopped.

Certain immune system genes are linked to a higher risk of psoriasis and psoriatic arthritis, while others may offer protection.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Sam Shuster identified three types of hair loss in psoriasis and emphasized the need for better research to understand them.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

Patients with Frontal fibrosing alopecia in Morocco often have skin conditions and thyroid disorders.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Methotrexate treatment for rheumatoid arthritis has a serious infection rate of about two per 100 patient-years.

The S100A4 protein is more common in psoriatic skin and could be a target for treating psoriasis.

The convention discussed various skin conditions and treatments, and highlighted the importance of vaccinations for patients on immune-altering medications.

The April 2016 JEADV issue covered various dermatology topics, including psoriasis, psoriatic arthritis, mTOR inhibitors, autoimmune diseases, photodynamic therapy, viral DNA in skin diseases, chronic hand eczema, and female hair loss.

The new synthetic retinoid RO 13-6298 effectively treated severe psoriasis at low doses with manageable side effects.

Anti-TNF therapy can cause hair loss and skin issues.

Tofacitinib may help treat nail dystrophy, especially when other treatments fail.

Methotrexate injection site reactions are rare but can be managed by changing injection sites and using topical treatments.

Nails can reveal important health information about skin and body conditions.

A woman developed hair loss after starting a treatment with adalimumab, suggesting this medication might cause hair loss.

Autoimmune and metabolic issues are linked, and treating one may worsen another.

Acitretin can cause eyebrow and eyelash hair loss.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

Acitretin treats severe skin conditions but requires careful monitoring due to serious side effects.

A woman's psoriasis improved after hepatitis C treatment with interferon, despite interferon's risk of worsening skin conditions.

Some moles can disappear naturally, maintenance therapy for Stage 1 mycosis fungoides may not be necessary, allergic skin reactions in children are rising, weekly methotrexate for psoriasis is more effective than daily, long-term finasteride use improves hair growth with few side effects, and petrolatum improves UV therapy for psoriasis.

A patient experienced long-lasting hair loss after using acitretin for psoriasis.

Use specific tools to measure quality of life in alopecia areata patients and improve future treatments.

Cholecystokinin may help reduce skin inflammation in psoriasis.

A woman developed psoriasis after taking certolizumab pegol, improving after stopping the drug and starting other treatments.

Syphilis patients showed abnormal hair root changes, with no difference between primary and secondary stages.